These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Subcutaneous Implantable Cardioverter Defibrillator Lead Repositioning for Preventing Inappropriate Shocks Due to Myopotential Oversensing in a Post-Fulminant Myocarditis Patient. Sasaki T; Nakamura K; Naito S Int Heart J; 2019 Mar; 60(2):466-469. PubMed ID: 30745542 [TBL] [Abstract][Full Text] [Related]
47. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population. Buber J; Luria D; Gurevitz O; Bar-Lev D; Eldar M; Glikson M Europace; 2014 Feb; 16(2):227-34. PubMed ID: 24108231 [TBL] [Abstract][Full Text] [Related]
48. Myocardial Irritation from a Left Ventricular Assist Device Resulting in Refractory Ventricular Tachycardia. Harper R; Ludwig J; Morcos M; Morris S J Emerg Med; 2019 Jan; 56(1):87-93. PubMed ID: 30355475 [TBL] [Abstract][Full Text] [Related]
50. [Implantable defibrillators. Clinical experience]. Mirowski M; Mower MM; Veltri EP; Juanteguy JM Ann Cardiol Angeiol (Paris); 1986 Dec; 35(10):589-95. PubMed ID: 3827149 [TBL] [Abstract][Full Text] [Related]
51. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator. Skowasch D; Ringquist S; Nickenig G; Andrié R PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033 [TBL] [Abstract][Full Text] [Related]
52. Early experience with the automatic implantable cardioverter defibrillator in sudden death survivors. Paull DL; Fellows CL; Guyton SW; Anderson RP Am J Surg; 1989 May; 157(5):516-8. PubMed ID: 2712211 [TBL] [Abstract][Full Text] [Related]
53. Automatic implantable cardioverter-defibrillator: techniques of implantation and results. Thurer RJ; Luceri RM; Bolooki H Ann Thorac Surg; 1986 Aug; 42(2):143-7. PubMed ID: 3741011 [TBL] [Abstract][Full Text] [Related]
54. Causes and Prevention of Inappropriate Implantable Cardioverter-Defibrillator Shocks. Kulkarni N; Link MS Card Electrophysiol Clin; 2018 Mar; 10(1):67-74. PubMed ID: 29428143 [TBL] [Abstract][Full Text] [Related]
55. [Automatic implantable cardioverter-defibrillator (AICD) and antitachycardia pacemaker (Tachylog 651) in the treatment of ventricular tachyarrhythmias]. Gerckens U; Manz M; Funke HD; Kirchhoff PG; Lüderitz B Z Kardiol; 1987 Apr; 76(4):211-6. PubMed ID: 3604373 [TBL] [Abstract][Full Text] [Related]
56. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry). Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618 [TBL] [Abstract][Full Text] [Related]
57. A Canadian hospital's experience with the automatic implantable cardioverter/defibrillator. Sharma AD; Guiraudon G; Klein GJ; Yee R CMAJ; 1987 Nov; 137(9):809-15. PubMed ID: 3442769 [TBL] [Abstract][Full Text] [Related]
58. Automatic implantable cardioverter/defibrillator discharges and acute myocardial injury. Avitall B; Port S; Gal R; McKinnie J; Tchou P; Jazayeri M; Troup P; Akhtar M Circulation; 1990 May; 81(5):1482-7. PubMed ID: 2158864 [TBL] [Abstract][Full Text] [Related]
60. Association of Antitachycardia Pacing or Shocks With Survival in 69,000 Patients With an Implantable Defibrillator. Strickberger SA; Canby R; Cooper J; Coppess M; Doshi R; John R; Connolly AT; Roberts G; Karst E; Daoud EG J Cardiovasc Electrophysiol; 2017 Apr; 28(4):416-422. PubMed ID: 28128491 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]